Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ruddy

Showing results (371-380 of 400) with videos related to

Pageof 40
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
NCCN Guidelines Insights: Survivorship, Version 1.2016Crystal S Denlinger, Jennifer A Ligibel, Madhuri Are, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in <i>ATM</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>CHEK2</i>, and <i>PALB2</i>Siddhartha Yadav, Nicholas J Boddicker, Jie Na, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
NCCN Guidelines® Insights: Survivorship, Version 1.2022Tara Sanft, Andrew Day, Lindsay Peterson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 2, 2021
Survivorship, Version 1.2021Amye Tevaarwerk, Crystal S Denlinger, Tara Sanft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2026
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) TrialOlivia Pagani, Samuel M Niman, Monica Ruggeri, et al.
ESMO Open|September 17, 2024
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histologyE Agostinetto, M Bruzzone, A-S Hamy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2025
Clinical Behavior of Breast Cancer in Young <i>BRCA</i> Carriers and Prediagnostic Awareness of Germline <i>BRCA</i> StatusMatteo Lambertini, Eva Blondeaux, Loredana M Tomasello, et al.
JAMA Oncology|October 9, 2025
Pathogenic Variants, Family History, and Cumulative Risk of Breast Cancer in US WomenKatie M O'Brien, Alexander P Keil, Jack A Taylor, et al.
NPJ Breast Cancer|February 17, 2022
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trialRomualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, et al.
The Lancet. Oncology|May 10, 2025
Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort studyEva Blondeaux, Amir Sonnenblick, Elisa Agostinetto, et al.
Pageof 40

Showing results (371-380 of 400) with videos related to

Sort By:
Pageof 40
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
NCCN Guidelines Insights: Survivorship, Version 1.2016Crystal S Denlinger, Jennifer A Ligibel, Madhuri Are, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in <i>ATM</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>CHEK2</i>, and <i>PALB2</i>Siddhartha Yadav, Nicholas J Boddicker, Jie Na, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
NCCN Guidelines® Insights: Survivorship, Version 1.2022Tara Sanft, Andrew Day, Lindsay Peterson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 2, 2021
Survivorship, Version 1.2021Amye Tevaarwerk, Crystal S Denlinger, Tara Sanft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2026
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) TrialOlivia Pagani, Samuel M Niman, Monica Ruggeri, et al.
ESMO Open|September 17, 2024
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histologyE Agostinetto, M Bruzzone, A-S Hamy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2025
Clinical Behavior of Breast Cancer in Young <i>BRCA</i> Carriers and Prediagnostic Awareness of Germline <i>BRCA</i> StatusMatteo Lambertini, Eva Blondeaux, Loredana M Tomasello, et al.
JAMA Oncology|October 9, 2025
Pathogenic Variants, Family History, and Cumulative Risk of Breast Cancer in US WomenKatie M O'Brien, Alexander P Keil, Jack A Taylor, et al.
NPJ Breast Cancer|February 17, 2022
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trialRomualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, et al.
The Lancet. Oncology|May 10, 2025
Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort studyEva Blondeaux, Amir Sonnenblick, Elisa Agostinetto, et al.
Pageof 40